Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15—34 years – a Swedish population-based study using EQ-5D

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Diabetes with onset in younger ages affects both length of life and health status due to debilitating and life-threatening long-term complications. In addition, episodes and fear of hypoglycaemia and of long-term consequences may have a substantial impact on health status. This study aims to describe and analyse health-related quality of life (HRQoL) in individuals with onset of diabetes at the age of 15—34 years and with a disease duration of 1, 8, 15 and 24 years compared with control individuals matched for age, sex and county of residence.

Methods

Cross-sectional study of 839 individuals with diabetes and 1564 control individuals. Data on socioeconomic status and HRQoL using EQ-5D were collected by a postal questionnaire. Insulin treatment was self-reported by 94% of the patients, the majority most likely being type 1.

Results

Individuals with diabetes reported lower HRQoL, with a significantly lower mean EQ VAS score in all cohorts of disease duration compared with control individuals for both men and women, and with a significantly lower EQ-5Dindex for women, but not for men, 15 years (0.76, p = 0.022) and 24 years (0.77, p = 0.016) after diagnosis compared with corresponding control individuals. Newly diagnosed individuals with diabetes reported significantly more problems compared with the control individuals in the dimension usual activities (women: 13.2% vs. 4.0%, p = 0.048; men: 11.4% vs. 4.1%, p = 0.033). In the other dimensions, differences between individuals with diabetes and control individuals were found 15 and 24 years after diagnosis: for women in the dimensions mobility, self-care, usual activities and pain/discomfort and for men in the dimension mobility. Multivariable regression analysis showed that diabetes duration, being a woman, having a lower education and not being married or cohabiting had a negative impact on HRQoL.

Conclusions

Our study confirms the negative impact of diabetes on HRQoL and that the difference to control individuals increased by disease duration for women with diabetes. The small difference one year after diagnosis could imply a good management of diabetes care and a relatively quick adaptation. Our results also indicate that gender differences still exist in Sweden, despite modern diabetes treatment and management in Sweden.
Appendix
Available only for authorised users
Literature
1.
Waernbaum I, Blohme G, Ostman J, Sundkvist G, Eriksson JW, Arnqvist HJ, Bolinder J, Nystrom L: Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia. 2006, 49 (4): 653-659. 10.1007/s00125-005-0135-x.CrossRefPubMed
2.
Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L: A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns. 2007, 68 (1): 10-15. 10.1016/j.pec.2007.05.003.CrossRefPubMed
3.
Anderbro T, Amsberg S, Adamson U, Bolinder J, Lins PE, Wredling R, Moberg E, Lisspers J, Johansson UB: Fear of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2010, 27 (10): 1151-1158. 10.1111/j.1464-5491.2010.03078.x.CrossRefPubMed
4.
Fayers P, Machin D: Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2007, Chichester: J. Wiley, 2CrossRef
5.
Matza LS, Boye KS, Yurgin N: Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Health Qual Life Outcomes. 2007, 5: 47-10.1186/1477-7525-5-47.CrossRefPubMedPubMedCentral
6.
Akinci F, Yildirim A, Gozu H, Sargin H, Orbay E, Sargin M: Assessment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey. Diabetes Res Clin Pract. 2008, 79 (1): 117-123. 10.1016/j.diabres.2007.07.003.CrossRefPubMed
7.
Fincke BG, Clark JA, Linzer M, Spiro A, Miller DR, Lee A, Kazis LE: Assessment of long-term complications due to type 2 diabetes using patient self-report: the diabetes complications index. J Ambul Care Manage. 2005, 28 (3): 262-273.CrossRefPubMed
8.
Graue M, Wentzel-Larsen T, Hanestad BR, Batsvik B, Sovik O: Measuring self-reported, health-related, quality of life in adolescents with type 1 diabetes using both generic and disease-specific instruments. Acta Paediatr. 2003, 92 (10): 1190-1196. 10.1111/j.1651-2227.2003.tb02483.x.CrossRefPubMed
9.
Ahola AJ, Saraheimo M, Forsblom C, Hietala K, Sintonen H, Groop PH, Group FS: Health-related quality of life in patients with type 1 diabetes–association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant. 2010, 25 (6): 1903-1908. 10.1093/ndt/gfp709.CrossRefPubMed
10.
Burstrom K, Johannesson M, Diderichsen F: Swedish population health-related quality of life results using the EQ-5D. Qual Life Res. 2001, 10 (7): 621-635. 10.1023/A:1013171831202.CrossRefPubMed
11.
Naughton MJ, Ruggiero AM, Lawrence JM, Imperatore G, Klingensmith GJ, Waitzfelder B, McKeown RE, Standiford DA, Liese AD, Loots B: Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study. Arch Pediatr Adolesc Med. 2008, 162 (7): 649-657. 10.1001/archpedi.162.7.649.CrossRefPubMed
12.
Dowie J: Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ. 2002, 11 (1): 1-8. 10.1002/hec.667.CrossRefPubMed
13.
Sikdar KC, Wang PP, MacDonald D, Gadag VG: Diabetes and its impact on health-related quality of life: a life table analysis. Qual Life Res. 2010, 19 (6): 781-787. 10.1007/s11136-010-9641-5.CrossRefPubMed
14.
Hart HE, Redekop WK, Bilo HJ, Berg M, Jong BM: Change in perceived health and functioning over time in patients with type I diabetes mellitus. Qual Life Res. 2005, 14 (1): 1-10. 10.1007/s11136-004-0782-2.CrossRefPubMed
15.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33 (5): 337-343. 10.3109/07853890109002087.CrossRefPubMed
16.
Fu AZ, Qiu Y, Radican L, Luo N: Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States. Qual Life Res. 2011, 20 (6): 825-832. 10.1007/s11136-010-9819-x.CrossRefPubMed
17.
Burstrom K, Johannesson M, Diderichsen F: Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy. 2001, 55 (1): 51-69. 10.1016/S0168-8510(00)00111-1.CrossRefPubMed
18.
Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002, 25 (3): 458-463. 10.2337/diacare.25.3.458.CrossRefPubMed
19.
Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M: Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health. 2000, 3 (Suppl 1): 47-51.CrossRefPubMed
20.
Hart HE, Bilo HJ, Redekop WK, Stolk RP, Assink JH, Meyboom-de Jong B: Quality of life of patients with type I diabetes mellitus. Qual Life Res. 2003, 12 (8): 1089-1097. 10.1023/A:1026197119569.CrossRefPubMed
21.
Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ: Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med. 2009, 169 (14): 1307-1316.CrossRefPubMedPubMedCentral
22.
Henricsson M, Nystrom L, Blohme G, Ostman J, Kullberg C, Svensson M, Scholin A, Arnqvist HJ, Bjork E, Bolinder J, Eriksson JW, Sundkvist G: The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003, 26 (2): 349-354. 10.2337/diacare.26.2.349.CrossRefPubMed
23.
Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A: Health utility values associated with diabetic retinopathy. Diabet Med. 2008, 25 (5): 618-624. 10.1111/j.1464-5491.2008.02430.x.CrossRefPubMed
24.
Ragnarson Tennvall G, Apelqvist J: Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000, 14 (5): 235-241. 10.1016/S1056-8727(00)00133-1.CrossRefPubMed
25.
Smith DH, Johnson ES, Russell A, Hazlehurst B, Muraki C, Nichols GA, Oglesby A, Betz-Brown J: Lower visual acuity predicts worse utility values among patients with type 2 diabetes. Qual Life Res. 2008, 17 (10): 1277-1284. 10.1007/s11136-008-9399-1.CrossRefPubMed
26.
Solli O, Stavem K, Kristiansen IS: Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010, 8: 18-10.1186/1477-7525-8-18.CrossRefPubMedPubMedCentral
27.
Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR: The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med. 2007, 24 (2): 187-194. 10.1111/j.1464-5491.2006.02057.x.CrossRefPubMed
28.
Hart HE, Redekop WK, Berg M, Bilo HJ, Meyboom-de Jong B: Factors that predicted change in health-related quality of life were identified in a cohort of diabetes mellitus type 1 patients. J Clin Epidemiol. 2005, 58 (11): 1158-1164. 10.1016/j.jclinepi.2005.02.021.CrossRefPubMed
29.
Ostman J, Lonnberg G, Arnqvist HJ, Blohme G, Bolinder J, Ekbom Schnell A, Eriksson JW, Gudbjornsdottir S, Sundkvist G, Nystrom L: Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002. J Intern Med. 2008, 263 (4): 386-394. 10.1111/j.1365-2796.2007.01896.x.CrossRefPubMed
30.
31.
Jonsson PM, Nystrom L, Sterky G, Wall S: Sociodemographic predictors of self-rated health in patients with diabetes of short duration. Scand J Public Health. 2001, 29 (4): 263-270.CrossRefPubMed
32.
Dolan P: Modeling valuations for EuroQol health states. Med Care. 1997, 35 (11): 1095-1108. 10.1097/00005650-199711000-00002.CrossRefPubMed
33.
Hart HE, Redekop WK, Assink JH, Meyboom-de Jong B, Bilo HJ: Health-related quality of life in patients with newly diagnosed type 1 diabetes. Diabetes Care. 2003, 26 (4): 1319-1320. 10.2337/diacare.26.4.1319.CrossRefPubMed
34.
Sparring V, Nystrom L, Ostman J, Wahlstrom R, Burstrom K, Jonsson PM: Changing healthcare utilization patterns in diabetes mellitus: case–control studies 1 year and 8 years after diagnosis. Diabet Med. 2012, 29 (6): 784-791. 10.1111/j.1464-5491.2011.03514.x.CrossRefPubMed
35.
National Board of Health and Welfare Guidelines for Diabetes Care. 2010, Stockholm: National Board of Health and Welfare
36.
Annual Report 2011: 2012, Statistics Sweden
37.
Metadata
Title
Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15—34 years – a Swedish population-based study using EQ-5D
Publication date
01-12-2013
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-377

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue

Research article

Respiratory symptoms and lung function 8–10 months after community exposure to chlorine gas: a public health intervention and cross-sectional analysis

Research article

Assessment of the relationship between bacteriological quality of dug-wells, hygiene behaviour and well characteristics in two cholera endemic localities in Douala, Cameroon

Research article

Fertility and contraceptive decision-making and support for HIV infected individuals: client and provider experiences and perceptions at two HIV clinics in Uganda

Research article

Prevalence and factors associated with syphilis in parturient women in Northeast, Brazil

Research article

Do accurate HIV and antiretroviral therapy knowledge, and previous testing experiences increase the uptake of HIV voluntary counselling and testing? Results from a cohort study in rural Tanzania

Research article

Changes and tracking of fruit, vegetables and sugar-sweetened beverages intake from 18 months to 7 years in the Norwegian mother and child cohort study